Brazil
Kintor’s COVID-19 treatment reduces mortality by 92%
March 12, 2021Medical Communications Brazil, Brazil variant, COVID-19, Kintor, covid-19 treatment
Kintor Pharmaceutical’s Proxalutamide treatment has been proven to reduce risk of mortality from COVID-19 by 92%, in a clinical trial …
Amryt’s Lojuxta approved in Brazil to reduce cholesterol in homozygous familial hypercholesterolaemia patients
December 9, 2020Research and Development, Sales and Marketing Amryt, Brazil, rare disease
Brazil’s National Health Surveillance Agency (ANVISA) has moved to authorise Amryt’s Lojuxta (lomitapide) in the country as a treatment for …
Sinovac COVID-19 trial suspended in Brazil due to severe adverse event
November 10, 2020Manufacturing and Production Brazil, COVID, COVID Vaccine, coronavirus
Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a …
Brazilian President Jair Bolsonaro tests positive for COVID-19, says he is taking hydroxychloroquine
July 8, 2020Research and Development Brazil, COVID-19, President of Brazil
Jair Bolsonaro, the President of Brazil, has tested positive for COVID-19 and says he treating the virus with hydroxychloroquine. The …
Glenmark signs deal with Novartis over distribution in Brazil
June 24, 2019Sales and Marketing Brazil, Glenmark, Latin America, Novartis, distribution, pharma
Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil. …
Measles outbreak threatens to decimate isolated Amazonian tribe in Venezuela and Brazil
October 25, 2018Medical Communications Brazil, Venezuela, measles, tribe, vaccines, yanomami
An outbreak of measles threatens to decimate an isolated tribe in the Amazon, according to the non-profit organisation Survival International. …
Brazil declares end to Zika virus emergency
May 12, 2017Medical Communications Brazil, Vaccine, Zika, Zika virus
Brazil has declared that the national emergency over the Zika virus threat is over, after there was a 95% drop …
Advent reportedly backs out of bid for Pfizer’s Brazil plant
March 23, 2017Sales and Marketing Brazil, Pfizer, generics
It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …
Sanofi launches dengue immunisation program in Brazil
August 15, 2016Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines
Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
Brazil focus: not just another BRIC in the wall
April 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BRIC, Brazil, emerging markets, market access, rio
Population: 198.7 million (2012) Government: Federal presidential republic Leader: President Dilma Rousseff of the centre-left Workers’ Party Gross Domestic Product: …
Valeant shuts plant in Brazil, second to follow
January 8, 2013Manufacturing and Production Brazil, Medicis, Valeant
Canadian firm Valeant Pharmaceuticals has closed down one of its facilities in Brazil and will shutter a second in the …
Brazil delays excipient GMP deadline
September 6, 2012Manufacturing and Production ANVISA, Brazil, GMP
Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …
Capturing the Brazilian pharma opportunity
May 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma
Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …
Access to new cancer drugs limited in Brazil and Mexico
April 13, 2012Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets
Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …
Merck unveils Brazilian joint venture
February 17, 2012Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets
Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …
